Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Gaze, Mark N*" or (type exact bookEditor and editor="Gaze, Mark N*")

Add to list
Overcoming inter-observer planning variability in target volume contouring and dose planning for high-risk neuroblastoma : a European multicenter effort of the SIOPEN Radiotherapy Committee

Danny Jazmati, Lorenzo Brualla, Annemieke S Littooij, Britta Webber, Karin Dieckmann, Geert O Janssens, Thorsten Simon, Mark N. Gaze, Julien Merta, Antonio Serrano, et al.

(2023) RADIOTHERAPY AND ONCOLOGY. 181.
Add to list
- Journal Article
- A1
- open access
QUARTET : a SIOP Europe project for quality and excellence in radiotherapy and imaging for children and adolescents with cancer

Sarah Kelly (UGent) , Rachel Effeney, Mark N. Gaze, Valérie Bernier-Chastagner, Anne Blondeel, Enrico Clementel, Coreen Corning, Karin Dieckmann, Samira Essiaf, Lorenza Gandola, et al.

(2022) EUROPEAN JOURNAL OF CANCER. 172. p.209-220
Add to list
- Miscellaneous
European clinical trials in paediatric radiation oncology

Tom Boterberg (UGent) , Cathy Dunlea, Semi Harrabi, Geert O Janssens, Anne Laprie, Gillian Whitfield and Mark N Gaze

(2021) LANCET CHILD & ADOLESCENT HEALTH. 5(12). p.843-845
Add to list
- Journal Article
- A1
- open access
Influence of surgical excision on the survival of patients with stage 4 high-risk neuroblastoma : a report from the HR-NBL1/SIOPEN study

Keith Holmes, Ulrike Pötschger, Andrew D. J. Pearson, Sabine Sarnacki, Giovanni Cecchetto, Javier Gomez-Chacon, Roly Squire, Enrique Freud, Adam Bysiek, Lucas Matthyssens (UGent) , et al.

(2020) JOURNAL OF CLINICAL ONCOLOGY. 38(25). p.2902-2916
Add to list
Radiotherapy practice for paediatric brain tumours across Europe and quality assurance initiatives : current situation, international survey and future perspectives

Teresa de Rojas, Enrico Clementel, Jordi Giralt, Ofelia Cruz, Tom Boterberg (UGent) , Rolf-Dieter Kortmann, Mark N Gaze, Lucas Moreno and Geert O Janssens

(2019) EUROPEAN JOURNAL OF CANCER. 114. p.36-46
Add to list
Interleukin 2 with anti-GD2 antibody ch14.18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN) : a multicentre, randomised, phase 3 trial

Ruth Ladenstein, Ulrike Poetschger, Dominique Valteau-Couanet, Roberto Luksch, Victoria Castel, Isaac Yaniv, Genevieve Laureys (UGent) , Penelope Brock, Jean Marie Michon, Cormac Owens, et al.

(2018) LANCET ONCOLOGY. 19(12). p.1617-1629
Add to list
Results of a quality assurance review of external beam radiation therapy in the International Society of Paediatric Oncology (Europe) Neuroblastoma Group's high-risk neuroblastoma trial: a SIOPEN study

Mark N Gaze, Tom Boterberg (UGent) , Karin Dieckmann, Marcus Hörmann, Jennifer E Gains, Kevin P Sullivan and Ruth Ladenstein

(2013) INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 85(1). p.170-174
Add to list
Development of an electronic database for quality assurance of radiotherapy in the International Society of Paediatric Oncology (Europe) high risk neuroblastoma study

Mark N Gaze, Tom Boterberg (UGent) , Karin Dieckmann, Jean-Louis Habrand, Sylvie Helfre, Nili Peylan-Ramu, Elzbieta Korab Chrzanowska, Guenter Schreier and Ruth Ladenstein

(2010) RADIOTHERAPY AND ONCOLOGY. 97(3). p.593-595

Academic Bibliography

Overcoming inter-observer planning variability in target volume contouring and dose planning for high-risk neuroblastoma : a European multicenter effort of the SIOPEN Radiotherapy Committee

QUARTET : a SIOP Europe project for quality and excellence in radiotherapy and imaging for children and adolescents with cancer

European clinical trials in paediatric radiation oncology

Influence of surgical excision on the survival of patients with stage 4 high-risk neuroblastoma : a report from the HR-NBL1/SIOPEN study

Radiotherapy practice for paediatric brain tumours across Europe and quality assurance initiatives : current situation, international survey and future perspectives

Interleukin 2 with anti-GD2 antibody ch14.18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN) : a multicentre, randomised, phase 3 trial

Results of a quality assurance review of external beam radiation therapy in the International Society of Paediatric Oncology (Europe) Neuroblastoma Group's high-risk neuroblastoma trial: a SIOPEN study

Development of an electronic database for quality assurance of radiotherapy in the International Society of Paediatric Oncology (Europe) high risk neuroblastoma study

Contents

Support

Contact